Ara A. Vaporciyan

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

Neostar Trial, Medicine, Immune Checkpoint Inhibitor +6

C5a-induced expression of P-selectin in endothelial cells.

Kimberly E. Foreman, Ara A. Vaporciyan, Brian K. Bonish et al. · Journal of Clinical Investigation · 1994 · 471 citations · Full text

Endothelial Cells, Cell Adhesion, Immunology +17

Involvement of Platelet-Endothelial Cell Adhesion Molecule-1 in Neutrophil Recruitment in Vivo

Ara A. Vaporciyan, Horace M. DeLisser, Horng-Chin Yan et al. · Science · 1993 · 459 citations

Lung Inflammation, Cell Adhesion, Immunology +19

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Apar Pataer, Neda Kalhor, Arlene M. Correa et al. · Journal of Thoracic Oncology · 2012 · 351 citations · Full text

Surgical Oncology, Neoadjuvant Chemotherapy, Resected Lung Cancer +10

Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients

Ara A. Vaporciyan, Arlene M. Correa, David C. Rice et al. · Journal of Thoracic and Cardiovascular Surgery · 2004 · 347 citations · Full text

Cardiothoracic Surgery, Cardiovascular Disease, Patient Safety +14